Celgene Announces Presentations Of Investigational Studies In Solid Tumor And Blood Cancers At ASCO 2015
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) today announced more than 55 presentations reporting on investigational studies in blood and solid tumor cancers will be presented during the 51st American Society of Clinical Oncology meeting in Chicago, Ill. from May 30 to June 2, 2015.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.